Abstract 3964: Co-targeting MDM2-p53 and BCL-2 apoptosis pathways overcomes resistance conferred by acquired BCL-2 gene mutations in preclinical models
Home » Abstract 3964: Co-targeting MDM2-p53 and BCL-2 apoptosis pathways overcomes resistance conferred by acquired BCL-2 gene mutations in preclinical models
2022
Deng J, Zhang K, Tang Q, Huang X, Wang Q, Li N, Fang DD, Yang DD, Zhai Y. Abstract 3964: Co-targeting MDM2-p53 and BCL-2 apoptosis pathways overcomes resistance conferred by acquired BCL-2 gene mutations in preclinical models. Cancer Res. vol. 82(suppl 12):, pp. 3964. [2022 AACR poster presentation]-3964. [2022 AACR poster presentation], View